EUVIMEDEUVIMED entdecken
Crossref

Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects

M. D. Jaaffer, A. M. Chaloop

Biopolymers and Cell · 24.04.2026 · 42 (1) · 54-67

DOI: 10.7124/bc.000b2e ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopolymers and Cell, erschienen am 24.04.2026. Verfasst von M. D. Jaaffer und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jaaffer, M. D., & Chaloop, A. M. (2026). Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects. Biopolymers and Cell, 42(1), 54-67. https://doi.org/10.7124/bc.000b2e

Vancouver

Jaaffer MD, Chaloop AM. Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects. Biopolymers and Cell. 2026;42(1):54-67. doi:10.7124/bc.000b2e

BibTeX
@article{Jaaffer2026,
  author = {Jaaffer, M. D. and Chaloop, A. M.},
  title = {Doxorubicin-PLGA nanoparticles are immunomodulational antitumor therapeutics with dual cytotoxic and immune-stimulatory effects},
  journal = {Biopolymers and Cell},
  year = {2026},
  volume = {42},
  number = {1},
  pages = {54--67},
  doi = {10.7124/bc.000b2e}
}
Kostenlos starten →